Indications, success, and adverse event rates of pediatric endoscopic retrograde cholangiopancreatography (ERCP): a systematic review and meta-analysis

Hosseini, Amirhossein; Sohouli, Mohammad Hassan; Sharifi, Elham; Sayyari, Aliakbar; Sridharan, Kannan; Tajalli, Saleheh; Imanzadeh, Negar; Fatahi, Somaye

doi:10.1186/s12887-023-04392-5

Cited by 3 publications

(1 citation statement)

References 63 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, post-ERCP pancreatitis (PEP) involves 3%–16% of patients with chronic relapsing pancreatitis ( 21 ). Although specific pediatric guidelines are lacking, hydration, indomethacin, and stenting can be considered and used as preventive mechanisms ( 21 – 24 ). A possible limitation of pediatric endoscopic therapy, as we experienced during ERCP, is the impossibility of inserting and making the stent progress through the duct/reducing the potential for drainage.…”

Section: Discussionmentioning

confidence: 99%

Case Report: Chronic pancreatitis in children as the cumulative effect of bilio-pancreatic abnormalities and genetic mutations

Destro,

Durante,

Salerno

et al. 2024

Front. Pediatr.

View full text Add to dashboard Cite

Pancreatitis, in general, is a high-morbidity condition. Genetic conditions and anatomic variants are sometimes seen, especially in children, where biliary etiologies and alcohol are less common than in adults. The decision to intervene, the combined operative-endoscopic strategy, and the timing pose unique challenges. We report the case of a 10-year-old boy with PRSS1 mutation and pancreatic duct duplication, discussing the management and reviewing the recent reports in the Literature.

show abstract

Section: Discussionmentioning

confidence: 99%

Case Report: Chronic pancreatitis in children as the cumulative effect of bilio-pancreatic abnormalities and genetic mutations

Destro,

Durante,

Salerno

et al. 2024

Front. Pediatr.

View full text Add to dashboard Cite

show abstract

Comparison of the efficacy of esophageal balloon dilatation and Botox injection, with esophageal balloon dilatation alone, in children with achalasia referred to Mofid children hospital (2020-2023)

Dara,

Aghaei,

Hosseini

et al. 2024

Preprint

View full text Add to dashboard Cite

Background: Achalasia is an esophageal motility disorder with symptoms like regurgitation, dysphagia, anorexia, and chronic cough. Effective treatments include pneumatic dilatation and myotomy. This study evaluated the combined use of botulinum toxin (Botox) injection and esophageal balloon dilation versus balloon dilation alone, analyzing recovery rates for gastrointestinal and non-gastrointestinal symptoms. Study method: This clinical trial involved an intervention group and historical controls. Patients with symptomatic achalasia referred to Mofid Hospital (2020-2023) received balloon dilatation with Botox injection. Historical controls had balloon dilatation alone. Botox was injected at four points in the Lower Esophageal Sphincter (LES) before balloon dilatation. Symptoms and growth parameters were monitored every three months for a year, then every six months, with annual follow-ups for three years. The study included 37 intervention and 31 control patients, and data were analyzed using SPSS 24 software. Results: From the onset of the study to the 36th month, the intervention group showed greater symptom improvement than the control group: nausea or vomiting (19%), regurgitation (21%), dysphagia to liquids (37%), dysphagia to solids (10%), globus sensation (10%), anorexia (2.14%), weight loss (18%), halitosis (15%), cough (44%), aspiration (18%), and refusal to eat (7%). Exceptions were chest pain (same in both groups) and heartburn (14% better in the control group). At 6 and 12 months, the intervention group improved in abdominal tenderness (4.2%), wheezing (7.11%), and coarse rales (20.9%). Radiological signs improved more in the intervention group: esophageal dilatation (11.6%), rat tail/bird beak sign (31.7%), tertiary contractions (10.4%), and reduced air-fluid level in the esophagus (upper to middle third: 17%, middle to lower third: 35.8%), except for the sigmoid esophagus (same in both groups). At 36 months, growth criteria in the intervention group increased: weight (4 kg), length (5.35 cm), BMI (1.47 units), Z score (0.65 units), and percentile (5.65 units). Conclusion: The combined balloon and Botox treatment has shown effectiveness in improving disease symptoms, physical examination results, growth criteria, and radiological findings. Further studies are recommended to potentially establish this approach as a national protocol.

show abstract

Charting Unexplored Territories: ERCP Indications and Complications in Pediatric Patients; A Cross-Sectional Study from 2022 to 2023

Shahramian,

Pandi,

Dehghani

et al. 2024

Iran J Pediatr

View full text Add to dashboard Cite

Background: There are ongoing concerns about the safety of endoscopic retrograde cholangiopancreatography (ERCP) in children, as recorded cases have shown complications. Objectives: The objective of this study is to investigate the indications, complications, and outcomes of ERCP in pediatric patients. Methods: This cross-sectional study was conducted at Namazi and Abu Ali Sina Hospitals between September 2022 and December 2023. The study focused on pediatric patients aged 1 month to 18 years undergoing ERCP. The demographics, indications for ERCP, pre-procedural imaging findings, and complications within 72 hours and up to 6 months after ERCP were extracted from medical records. Results: During the study period, a total of 100 ERCP procedures were performed on 56 pediatric patients. The mean age of the patients was 10.22 ± 4.80 years, with females accounting for 53.6% of the group. The main indications for performing ERCP were the presence of a stricture after orthotopic liver transplantation (22%) and the presence of a common bile duct stone (19%). The incidence of complications was notable for acute pancreatitis (3%) and bleeding (2%), while the failure rate for ERCP operations was determined to be 4%. Conclusions: The infrequent occurrence of failures and complications highlights the substantial benefit of ERCP in treating biliary and pancreatic illnesses in children.

show abstract

Indications, success, and adverse event rates of pediatric endoscopic retrograde cholangiopancreatography (ERCP): a systematic review and meta-analysis

Cited by 3 publications

References 63 publications

Case Report: Chronic pancreatitis in children as the cumulative effect of bilio-pancreatic abnormalities and genetic mutations

Case Report: Chronic pancreatitis in children as the cumulative effect of bilio-pancreatic abnormalities and genetic mutations

Comparison of the efficacy of esophageal balloon dilatation and Botox injection, with esophageal balloon dilatation alone, in children with achalasia referred to Mofid children hospital (2020-2023)

Charting Unexplored Territories: ERCP Indications and Complications in Pediatric Patients; A Cross-Sectional Study from 2022 to 2023

Contact Info

Product

Resources

About